Structural analysis reveals an unexpected mechanism for a cancer drug
Palbociclib is clinically approved for use in treating breast cancer, but according to a new study, the molecular mechanism behind the drug's effectiveness is not what scientists had thought it was.
Dec 18, 2019
0
76
